Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT02277769 · COMPLETED
Trial details
- NCT number
- NCT02277769
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-30
- Primary completion
- 2015-10-31
- Enrollment
- 708
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.